Earnings call scheduled for Q2 FY27 results on Nov 6, 2026

Board & Shareholder Meetings View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹1391.00

prior close

₹1395.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-2.3%+2.7% vs market

Pharmaceuticals peers, median of 172sector-1.7%+2.1% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Smallcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.4

15m

-0.1

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5-2.3+2.7-1.7+2.1

Next day

+0.4-3.3+3.7-2.2+2.6

+0.3-6.0+6.3-3.5+3.8

+3.5-5.0+8.5-2.4+5.9

+6.8pendingpending-1.2+8.0

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences will host an earnings conference call on November 6, 2026 at 11:00 AM IST to discuss unaudited standalone and consolidated financial results for Q2 and H1 FY27 (quarter ended September 30, 2026). MD and CEO Krishna Kanumuri and CFO Siva Chittor will represent management. The call will begin with management discussion followed by a Q and A session. Dial-in numbers for India and international callers are provided in the filing.

Likely market impact

Routine earnings call intimation. Investors and analysts can tune in on Nov 6 for management commentary on Q2 performance and outlook.